Revenge of the Nerds

It was revenge of the nerds this week with the formerly lagging large value stocks up sharply while the effervescent large growth stocks, who had benefited from online shopping and work at home, were modestly lower.  News of a successful phase 3 trial of a vaccine and an antibody treatment, submitted for emergency use authorization, […]